Antifungal properties of 5-hydroxytryptamine (serotonin) against Candida species in vitro

被引:15
|
作者
Lass-Flörl, C
Fuchs, D
Ledochowski, M
Speth, C
Dierich, MP
Würzner, R
机构
[1] Univ Innsbruck, Inst Hyg & Social Med, A-6020 Innsbruck, Austria
[2] Univ Innsbruck Hosp, Dept Clin Nutr, A-6020 Innsbruck, Austria
关键词
D O I
10.1099/jmm.0.04987-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study the minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of 5-hydroxytryptamine (5 HT, serotonin) against clinical isolates of Candida albicans (n = 11), Candida glabrata (n = 9), Candida tropicalis (n = 10) and Candida parapsilosis (ATCC 22019) using a broth microdilution test were investigated. In addition, it was examined whether delayed regrowth as a post-antifungal effect results following short exposure to 5 HT. 5 HT showed antifungal activity towards all isolates of Candida spp. The isolates yielded comparable MIC and MFC values of 5 HT in the range 0.91 - 7.34 mM and 1.83 - 14.68 mM, respectively, A lag in regrowth was dependent on the concentration tested. Treatment for 3 h at concentrations of 5 HT below and equipotent to the MFC resulted in a delayed regrowth of 8-12 h for isolates of Candida spp. In conclusion, these in vitro studies clearly demonstrate antifungal effects of 5 HT. Identifying the mode of action could be of great help in developing and researching new antifungal drugs.
引用
收藏
页码:169 / 171
页数:3
相关论文
共 50 条
  • [1] Antifungal properties of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro
    Lass-Flörl, C
    Wiedauer, B
    Mayr, A
    Kirchmair, M
    Jenewein, I
    Ledochowski, M
    Dierich, MP
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 291 (08) : 655 - 657
  • [2] Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro
    Perkhofer, Susanne
    Niederegger, Harald
    Blum, Gerhard
    Burgstaller, Wolfgang
    Ledochowski, Maximilian
    Dierich, Manfred P.
    Lass-Floerl, Cornelia
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (04) : 424 - 429
  • [3] SEROTONIN (5-HYDROXYTRYPTAMINE)
    PAGE, IH
    PHYSIOLOGICAL REVIEWS, 1954, 34 (03) : 563 - 588
  • [4] THE PHARMACOLOGY OF 5-HYDROXYTRYPTAMINE (SEROTONIN)
    FREYBURGER, WA
    GRAHAM, BE
    RAPPORT, MM
    SEAY, PH
    GOVIER, WM
    SWOAP, OF
    VANDERBROOK, MJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1952, 105 (01): : 80 - 86
  • [5] ANTIGENICITY OF 5-HYDROXYTRYPTAMINE (SEROTONIN)
    RANADIVE, NS
    FEDERATION PROCEEDINGS, 1966, 25 (2P1) : 725 - &
  • [6] METABOLISM OF SEROTONIN (5-HYDROXYTRYPTAMINE)
    MCISAAC, WM
    PAGE, IH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1959, 234 (04) : 858 - 864
  • [7] SPECIES DIFFERENCES IN THE RESPIRATORY AND CARDIOVASCULAR RESPONSE TO SEROTONIN (5-HYDROXYTRYPTAMINE)
    SCHNEIDER, JA
    YONKMAN, FF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1954, 111 (01): : 84 - 98
  • [8] TURNOVER OF 5-HYDROXYTRYPTAMINE (SEROTONIN) IN TISSUES
    UDENFRIEND, S
    WEISSBACH, H
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1958, 97 (04): : 748 - 751
  • [9] 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract
    Gershon, Michael D.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2013, 20 (01) : 14 - 21
  • [10] SEROTONIN (5-HYDROXYTRYPTAMINE, 5-HT)
    GRAHAMESMITH, DG
    QUARTERLY JOURNAL OF MEDICINE, 1988, 67 (254): : 459 - 466